SL Science Submits Orphan Drug Designation Request To FDA For Gamma Delta T Cell Therapy Product, Vdelta2+ Gamma Delta T Cells, For Treatment Of Glioblastoma Multiforme

뉴스 본문을 불러오고 있어요.

SL Science Submits Orphan Drug Designation Request To FDA For Gamma Delta T Cell Therapy Product, Vdelta2+ Gamma Delta T Cells, For Treatment Of Glioblastoma Multiforme | 웨이프 WAPE

SL Science Submits Orphan Drug Designation Request To FDA For Gamma Delta T Cell Therapy Product, Vdelta2+ Gamma Delta T Cells, For Treatment Of Glioblastoma Multiforme

기사 요약

관련 종목

댓글 —